AI
UTHR icon

Axiom Investors’s United Therapeutics UTHR Stock Holding History

Axiom Investors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.5M Buy
54,437
+53,632
+6,662% +$30.2M 0.26% 41
2026
Q1 		$477K Buy
+805
New +$401K 0.01% 114
2025
Q2 		– Sell
-1,621
Closed -$500K – 152
2025
Q1 		$500K Sell
1,621
-8,419
-84% -$2.89M ﹤0.01% 133
2024
Q4 		$3.54M Buy
10,040
+853
+9% +$314K 0.03% 117
2024
Q3 		$3.29M Sell
9,187
-4,595
-33% -$1.55M 0.03% 114
2024
Q2 		$4.39M Buy
13,782
+868
+7% +$230K 0.04% 111
2024
Q1 		$2.97M Buy
12,914
+4,279
+50% +$966K 0.03% 121
2023
Q4 		$1.9M Buy
8,635
+4,210
+95% +$970K 0.02% 120
2023
Q3 		$999K Buy
4,425
+1,229
+38% +$283K 0.01% 116
2023
Q2 		$706K Sell
3,196
-227
-7% -$50.3K 0.01% 122
2023
Q1 		$767K Sell
3,423
-1,043
-23% -$257K 0.01% 124
2022
Q4 		$1.24M Sell
4,466
-33
-0.7% -$8.33K 0.02% 112
2022
Q3 		$942K Sell
4,499
-4,122
-48% -$922K 0.02% 116
2022
Q2 		$2.03M Buy
8,621
+2,052
+31% +$417K 0.06% 104
2022
Q1 		$1.18M Sell
6,569
-10,029
-60% -$1.91M 0.03% 109
2021
Q4 		$3.59M Buy
16,598
+5,388
+48% +$1.06M 0.07% 94
2021
Q3 		$2.07M Sell
11,210
-13,912
-55% -$2.74M 0.03% 114
2021
Q2 		$4.51M Buy
25,122
+4,300
+21% +$819K 0.07% 92
2021
Q1 		$3.48M Buy
+20,822
New +$3.47M 0.06% 106

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Axiom Investors's UTHR Position: Q2 2026 in Review

Axiom Investors increased its United Therapeutics (UTHR) stake by 6,662% in Q2 2026, buying an estimated $30.2M and bringing the position to 54,437 shares worth $29.5M. The position accounts for 0.26% of the portfolio, ranked #41.

Axiom Investors first reported a position in UTHR in Q1 2021 and has held it in 19 quarters since. 877 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Axiom Investors held 54,437 shares of United Therapeutics worth $29.5M as of Q2 2026.
  • Axiom Investors bought 53,632 United Therapeutics shares in Q2 2026, an estimated $30.2M.
  • United Therapeutics made up 0.26% of Axiom Investors's portfolio in Q2 2026, its #41 holding.
  • Axiom Investors first reported a position in United Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • 877 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Axiom Investors's 13F filing for Q2 2026, filed 12 Aug 2026.